Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Centrica strikes nuclear deal with US firm

(Sharecast News) - Centrica has struck a major deal with America's X-energy to build modular nuclear reactors in the UK, the British firm confirmed on Monday. The British Gas owner, Britain's largest energy supplier, said it had signed a joint development agreement to deploy X-energy's Xe-100 advanced modular reactors (AMRs) in the UK.

Twelve 80-megawatt reactors will initially be installed at a site in Hartlepool. Once complete, the site will be capable of powering 1.5m homes, Centrica said.

It is the latest move by Centrica into nuclear. Earlier this year it agreed to invest £1.3bn for a 15% stake in the large-scale Sizewell C project in Suffolk.

Chris O'Shea, chief executive, said: "Centrica is proud to be at the forefront of Britain's clean energy transition.

"Our partnership with X-energy markets a bold step forward in delivering advanced nuclear technology that is not only scalable and secure, but vital to clean industry and powering homes."

Clay Sell, chief executive of the privately-owned X-energy, said: "We aim to build that fleet that has the ability to reliably deliver clean power, strengthen energy security and grow the trans-Atlantic economy for decades to come."

The AMRs - which are smaller and more flexible than traditional nuclear reactors - have already been designed. A commercial manufacturing plant is now under development on the Texas Gulf Coast. The plant is being developed jointly by X-energy and Dow Inc.

Under the terms of its deal with X-energy, Centrica will provide initial project capital with the goal of initiating full-scale activities in 2016.

Financial details were not disclosed. However, O'Shea told the Financial Times that the Hartlepool site would cost roughly £10bn and require government backing, in the form of a construction levy on electricity bills.

The site is already home to a nuclear power station, but it is being decommissioned. It is due to stop producing electricity from 2028.

Russ Mould, investment direct at AJ Bell, said: "During the energy crisis which followed Russia's invasion of Ukraine, Centrica saw big increases in profit and cash flow from higher prices.

"But questions could be asked of its long-term strategy and how it might continue to prosper when market conditions are not so helpful.

"In this context, news of its involvement in a US-UK venture, to create a golden age of nuclear in this country, are positive.

"However, it is telling that the first US small modular reactor (SMR) project, the Carbon Free Power Project, was cancelled less than two years ago due to rising costs. This is a new area and the path towards operational SMRs may not be smooth."

As at 1000 BST, shares in Centrica were up 3% at 164.95p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.